Prothena Aktie
8,35
EUR
±0,00
EUR
±0,00
%
9,73
USD
-0,16
USD
-1,62
%
Werbung
Prothena Aktie Analyse
| 21.05.18 | Prothena Underweight | Barclays Capital | |
| 05.04.18 | Prothena overweight | Barclays Capital | |
| 20.11.17 | Prothena Neutral | Wedbush Morgan Securities Inc. | |
| 29.09.17 | Prothena Buy | BTIG Research | |
| 12.04.17 | Prothena Overweight | Cantor Fitzgerald | |
| 02.03.17 | Prothena Buy | Instinet | |
| 21.12.16 | Prothena buy | SunTrust | |
| 03.11.16 | Prothena Buy | Deutsche Bank AG | |
|
Werbung
|
|||
| 13.05.16 | Prothena overweight | Barclays Capital | |
| 19.11.15 | Prothena Outperform | RBC Capital Markets | |
| 22.07.15 | Prothena Outperform | RBC Capital Markets | |
| 03.06.15 | Prothena Outperform | Oppenheimer & Co. Inc. | |
| 29.05.15 | Prothena Buy | UBS AG | |
Werbung
Werbung